IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital LLC

Q1 2018 Holdings

Filed 2018-05-14 | 10 holdings | $17.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics Inc.(ADMA)COM000899104$16.6M3,608,17196.8%
Loxo Oncology Inc.COM548862101$396.7K3,438,9202.3%
Aimmune Therapeutics Inc.(AIMT)COM00900T107$71.3K2,240,0000.4%
Viewray Inc.(VRAYQ)COM92672L107$48.1K7,480,8870.3%
Transenterix Inc.COM NEW89366M201$16.8K9,889,3520.1%
Cidara Therapeutics Inc.COM171757107$4.1K1,021,1480.0%
Agile Therapeutics Inc.(AGRXUSD)COM00847L100$3.4K1,304,9330.0%
Chimerix Inc.(CMRXEUR)COM16934W106$2.5K472,9430.0%
Pernix Therapeutics Hldgs Inc.DEBT 4.250% 4/071426VAK4$1.2K$2,500,0000.0%
Pernix Therapeutics Hldgs Inc.COM NEW71426V306$502210,0000.0%